Home
electronic Nail Assessment in Psoriasis and Psoriatic Arthritis
eNAPPA
Nail Assessment made easy and quick
How to use the eNAPPA
The NAPPA-QOL and NAPPA-PBI questionnaires are filled in by the patient himself. The questionnaire is self-explanatory; yet, patients can be supported if they are not able to fill it in by themselves.The NAPPA-CLIN is filled by the dermatologist or assisting persons. This part needs a basic understanding of clinical signs at the nails.
Â
The three components (modules) have been developed and validated on an international basis. Thus, several language versions are available. The modules can be used independently from each other.
Â
Following you can find the versions of the eNAPPA
The impact of nail psoriasis
More than 50% of moderate to severe psoriasis patients have nail involvement which in many cases causes functional and emotional impairment and can be painful. Measurement of patient-related outcomes is essential for research and clinical care.
Â
Features

USER-FRIENDLY
eNAPPA is straight-forward to use allowing it to be used by clinicians from a range of different disciplines.

QUICK AND ACCURATE DIAGNOSIS
eNAPPA helps clinicians quickly and accurately assess nail psoriasis outcomes.

ENVIRONMENTALLY FRIENDLY
Put an end to wasting paper and store all your patient data in one online platform. Results can be shared via email.

MULTILINGUAL
eNAPPA is available in various languages for more comfortable and precise diagnostic process.

RESPONSIVE AND MULTI-DEVICE
Your eNAPPA is always a couple of touches or clicks away, available on desktop, tablet, phone and other devices.

MULTIDIMENSIONAL SCALES
The NAPPA-PBI, NAPPA-QOL and NAPPA-CLIN are part of the eNAPPA assessment.
References
Augustin M, Blome C, Costanzo A, Dauden E, Ferrandiz C, Girolomoni G, Gniadecki R, Iversen L, Menter A, Michaelis-Wittern K, Morita A, Nakagawa H, Reich K. Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. Br J Dermatol. 2014 Mar;170(3):591-8. doi: 10.1111/bjd.12664. PMID: 24117393.
Our Further Tools
Our partners
